• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自人鼻病毒14-1型人类免疫缺陷病毒(HIV-1)V3环血清阳性文库的嵌合体可诱导针对HIV-1的中和反应。

Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.

作者信息

Resnick D A, Smith A D, Gesiler S C, Zhang A, Arnold E, Arnold G F

机构信息

Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey 08854.

出版信息

J Virol. 1995 Apr;69(4):2406-11. doi: 10.1128/JVI.69.4.2406-2411.1995.

DOI:10.1128/JVI.69.4.2406-2411.1995
PMID:7884887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC188914/
Abstract

A chimeric virus library was designed whereby sequences corresponding to the V3 loop of human immunodeficiency virus type 1 (HIV-1) were presented on the surface of human rhinovirus 14. The V3 loop sequences consisted of a relatively conserved segment of seven amino acids and five adjacent residues that were allowed to vary in proportion to their seroprevalence among HIV-1 isolates of North America and Europe. A technique called random systematic mutagenesis was used to incorporate the composite V3 loop sequences flanked by zero to two randomized amino acids. This library could contain 2.7 x 10(8) members having diverse sequences and conformations. Immunoselection of a portion of this library by using two neutralizing V3 loop-directed monoclonal antibodies followed by selection for desirable growth and purification characteristics yielded a set of chimeric rhinoviruses, five of which are described. The inserted sequences in the five chimeras do not match those of any known isolate of HIV-1. Nonetheless, all five chimeras were neutralized by antibodies directed against different strains of HIV-1 and were able to elicit the production of antibodies that bind V3 loop peptides from diverse HIV-1 isolates. Moreover, antisera derived from four of the five chimeras were capable of neutralizing one or more strains of HIV-1 in cell culture. This study demonstrates that random systematic mutagenesis in conjunction with antibody screening is a powerful and efficient means to obtain antigenic chimeras with relevant immunogenic properties.

摘要

构建了一个嵌合病毒文库,其中与1型人类免疫缺陷病毒(HIV-1)V3环相对应的序列呈现在人鼻病毒14的表面。V3环序列由一段相对保守的七个氨基酸片段和五个相邻残基组成,这五个相邻残基在北美和欧洲的HIV-1分离株中的血清阳性率成比例变化。采用一种称为随机系统诱变的技术,将两侧带有零至两个随机氨基酸的复合V3环序列整合进去。该文库可能包含2.7×10⁸个具有不同序列和构象的成员。用两种中和性V3环导向的单克隆抗体对该文库的一部分进行免疫筛选,然后选择具有理想生长和纯化特性的病毒,得到了一组嵌合鼻病毒,本文描述了其中五种。这五种嵌合体中插入的序列与任何已知的HIV-1分离株的序列都不匹配。尽管如此,所有五种嵌合体都被针对不同HIV-1毒株的抗体中和,并且能够引发产生结合来自不同HIV-1分离株的V3环肽的抗体。此外,来自这五种嵌合体中四种的抗血清能够在细胞培养中中和一种或多种HIV-1毒株。这项研究表明,随机系统诱变与抗体筛选相结合是获得具有相关免疫原性特性的抗原性嵌合体的一种强大而有效的方法。

相似文献

1
Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.来自人鼻病毒14-1型人类免疫缺陷病毒(HIV-1)V3环血清阳性文库的嵌合体可诱导针对HIV-1的中和反应。
J Virol. 1995 Apr;69(4):2406-11. doi: 10.1128/JVI.69.4.2406-2411.1995.
2
Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.14型人鼻病毒:来自组合文库的人免疫缺陷病毒1型(HIV-1)V3环嵌合体可诱导针对HIV-1的强效中和抗体反应。
J Virol. 1998 Jan;72(1):651-9. doi: 10.1128/JVI.72.1.651-659.1998.
3
Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.
AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S47-52.
4
Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.利用随机系统诱变生成展示1型人类免疫缺陷病毒V3环序列的可行的人鼻病毒14嵌合体。
J Virol. 1994 Jan;68(1):575-9. doi: 10.1128/JVI.68.1.575-579.1994.
5
A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.人鼻病毒14表面的一个二硫键连接的HIV-1 V3环序列可诱导针对HIV-1的中和反应。
Biol Chem. 1999 Mar;380(3):365-74. doi: 10.1515/BC.1999.048.
6
Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.含有修饰包膜糖蛋白的基因工程化人免疫缺陷病毒样颗粒的表达与特性:对开发交叉保护性艾滋病疫苗的意义
J Virol. 1992 Jul;66(7):4003-12. doi: 10.1128/JVI.66.7.4003-4012.1992.
7
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
8
Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.针对1型人类免疫缺陷病毒V3环的单克隆抗体对N-连接寡糖的快速筛选。
J Gen Virol. 1996 Apr;77 ( Pt 4):753-8. doi: 10.1099/0022-1317-77-4-753.
9
Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.1型人类免疫缺陷病毒包膜内V3环环境的改变增强了中和作用。
J Virol. 1994 Jun;68(6):3459-66. doi: 10.1128/JVI.68.6.3459-3466.1994.
10
Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1.与野生型1型人类免疫缺陷病毒相比,针对V3环的中和抗体在具有突变逆转录酶(M184V)的病毒中选择出不同的逃逸变体。
AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):735-40. doi: 10.1089/aid.1998.14.735.

引用本文的文献

1
Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine.将普通感冒改造为活减毒 SARS-CoV-2 疫苗。
Front Immunol. 2022 Sep 8;13:871463. doi: 10.3389/fimmu.2022.871463. eCollection 2022.
2
Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.嵌合鼻病毒展示 MPER 表位可引发抗 HIV 中和反应。
PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013.
3
HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.在腺病毒六邻体超变区 2 中掺入 HIV 抗原,以开发新型 HIV 疫苗。
PLoS One. 2010 Jul 27;5(7):e11815. doi: 10.1371/journal.pone.0011815.
4
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].基于计算机设计增强 HIV-1 gp41 表位呈递的嵌合鼻病毒的抗原特性 [更正]。
J Mol Biol. 2010 Apr 2;397(3):752-66. doi: 10.1016/j.jmb.2010.01.064. Epub 2010 Feb 4.
5
Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.模拟与HIV-1中和抗体结合的V3表位的结构。
Biochemistry. 2009 Apr 21;48(15):3288-303. doi: 10.1021/bi802308n.
6
Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.从展示HIV-1 gp41 ELDKWA表位的人鼻病毒中引发的对1型人类免疫缺陷病毒(HIV-1)的广泛中和作用。
J Virol. 2009 May;83(10):5087-100. doi: 10.1128/JVI.00184-09. Epub 2009 Mar 11.
7
In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes.基于呈现HIV-1 gp41表位的鼻病毒嵌合体分子模拟的计算机疫苗设计。
J Mol Biol. 2009 Jan 16;385(2):675-91. doi: 10.1016/j.jmb.2008.10.089. Epub 2008 Nov 8.
8
Cowpea mosaic virus as a vaccine carrier of heterologous antigens.豇豆花叶病毒作为异源抗原的疫苗载体。
Mol Biotechnol. 2001 Jan;17(1):15-26. doi: 10.1385/MB:17:1:15.
9
Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.经鼻或口服给予嵌合植物病毒颗粒可在小鼠体内诱导全身和黏膜免疫反应。
J Virol. 1999 Feb;73(2):930-8. doi: 10.1128/JVI.73.2.930-938.1999.
10
Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.14型人鼻病毒:来自组合文库的人免疫缺陷病毒1型(HIV-1)V3环嵌合体可诱导针对HIV-1的强效中和抗体反应。
J Virol. 1998 Jan;72(1):651-9. doi: 10.1128/JVI.72.1.651-659.1998.

本文引用的文献

1
Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.与人类鼻病毒14复合的抗病毒化合物SCH 38057的结构测定
J Mol Biol. 1993 Apr 5;230(3):857-67. doi: 10.1006/jmbi.1993.1206.
2
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.成熟裂解在小核糖核酸病毒感染性中的作用:感染小体的激活。
J Virol. 1993 Apr;67(4):2110-22. doi: 10.1128/JVI.67.4.2110-2122.1993.
3
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.1型人类免疫缺陷病毒中和抗体50.1与其V3环肽抗原复合物的晶体结构。
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6325-9. doi: 10.1073/pnas.90.13.6325.
4
Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.利用随机系统诱变生成展示1型人类免疫缺陷病毒V3环序列的可行的人鼻病毒14嵌合体。
J Virol. 1994 Jan;68(1):575-9. doi: 10.1128/JVI.68.1.575-579.1994.
5
Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.豇豆花叶病毒作为一种用于展示外源肽的高产系统的开发。
Virology. 1994 Aug 1;202(2):949-55. doi: 10.1006/viro.1994.1417.
6
Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.
AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S47-52.
7
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1.嵌合流感病毒诱导产生针对1型人类免疫缺陷病毒的中和抗体和细胞毒性T细胞。
J Virol. 1993 Nov;67(11):6659-66. doi: 10.1128/JVI.67.11.6659-6666.1993.
8
Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.通过肽免疫可引发针对HIV-1 V3区的广泛中和单克隆抗体。
Virology. 1993 Jan;192(1):197-206. doi: 10.1006/viro.1993.1022.
9
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.通过筛选随机噬菌体表位文库鉴定HIV疫苗候选肽
Virology. 1993 Apr;193(2):709-16. doi: 10.1006/viro.1993.1179.
10
Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.抗gp41人单克隆抗体IAM-41-2F5对不同的1型人类免疫缺陷病毒变体和原代分离株的中和作用
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3348-52. doi: 10.1073/pnas.91.8.3348.